These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 14985310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group.
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [Abstract] [Full Text] [Related]

  • 4. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL, DCC/EDIC Research Group.
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ, Pittsburgh Epidemiology of Diabetes Complications Study.
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [Abstract] [Full Text] [Related]

  • 6. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Garvey WT, Lyons TJ, DCCT/EDIC Research Group.
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [Abstract] [Full Text] [Related]

  • 7. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Timothy Garvey W, Lyons TJ, DCCT/EDIC Research Group.
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [Abstract] [Full Text] [Related]

  • 8. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [Abstract] [Full Text] [Related]

  • 11. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Lefrandt JD.
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [Abstract] [Full Text] [Related]

  • 12. Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA).
    Kreis AJ, Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Jenkins AJ, Shea S, Wang JJ.
    Diab Vasc Dis Res; 2009 Jan; 6(1):40-2. PubMed ID: 19156628
    [Abstract] [Full Text] [Related]

  • 13. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
    Soedamah-Muthu SS, Colhoun HM, Thomason MJ, Betteridge DJ, Durrington PN, Hitman GA, Fuller JH, Julier K, Mackness MI, Neil HA, CARDS Investigators.
    Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
    [Abstract] [Full Text] [Related]

  • 14. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.
    Choo J, Ueshima H, Curb JD, Shin C, Evans RW, El-Saed A, Kadowaki T, Okamura T, Nakata K, Otake T, Miura K, Abbott RD, Sutton-Tyrrell K, Edmundowicz D, Kuller LH, Sekikawa A, ERA-JUMP Study Group.
    Am J Clin Nutr; 2010 May; 91(5):1195-203. PubMed ID: 20357040
    [Abstract] [Full Text] [Related]

  • 15. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
    Klein RL, Carter RE, Jenkins AJ, Lyons TJ, Baker NL, Gilbert GE, Virella G, Lopes-Virella MF, DCCT/EDIC Research Group.
    J Diabetes Complications; 2011 May; 25(2):73-82. PubMed ID: 20605479
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    J Diabetes Complications; 2005 Jan; 19(1):18-25. PubMed ID: 15642486
    [Abstract] [Full Text] [Related]

  • 18. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA.
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [Abstract] [Full Text] [Related]

  • 19. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M, Arrol S.
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [Abstract] [Full Text] [Related]

  • 20. A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra.
    Mihaleva VV, van Schalkwijk DB, de Graaf AA, van Duynhoven J, van Dorsten FA, Vervoort J, Smilde A, Westerhuis JA, Jacobs DM.
    Anal Chem; 2014 Jan 07; 86(1):543-50. PubMed ID: 24319989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.